BACKGROUND/AIM: The tetrazolium-based MTT cytotoxicity assay is well established for screening putative anti-cancer agents. However, it has limitations including lack of reproducibility with glioma cells treated with polyphenols. The aim of this study was to evaluate whether a flow cytometric assay with the anthraquinone, DRAQ7, was a better alternative than the colorimetric MTT assay for measuring cell viability. MATERIALS AND METHODS: Two glioma cell lines (IPSB-18, U373) and 1 pancreatic cancer cell line (AsPC-1) were treated with 4 polyphenols, namely red grape seed extract, red clover extract, anthocyanin-rich extract and curcumin. Cell viability was assessed using MTT assay and DRAQ7 staining. RESULTS: Limitations of MTT assay included lack of sensitivity and interference with the structure and absorbance spectra of polyphenols. Also, DMSO was toxic to glioma cells. Microscopic observations of cells treated with polyphenols confirmed the range of IC50 values evaluated by DRAQ7, but not by the MTT assay. CONCLUSION: DRAQ7 is a better alternative than MTT for measuring viability of glioma cells treated with brightly coloured polyphenols. Copyright
BACKGROUND/AIM: The tetrazolium-based MTT cytotoxicity assay is well established for screening putative anti-cancer agents. However, it has limitations including lack of reproducibility with glioma cells treated with polyphenols. The aim of this study was to evaluate whether a flow cytometric assay with the anthraquinone, DRAQ7, was a better alternative than the colorimetric MTT assay for measuring cell viability. MATERIALS AND METHODS: Two glioma cell lines (IPSB-18, U373) and 1 pancreatic cancer cell line (AsPC-1) were treated with 4 polyphenols, namely red grape seed extract, red clover extract, anthocyanin-rich extract and curcumin. Cell viability was assessed using MTT assay and DRAQ7 staining. RESULTS: Limitations of MTT assay included lack of sensitivity and interference with the structure and absorbance spectra of polyphenols. Also, DMSO was toxic to glioma cells. Microscopic observations of cells treated with polyphenols confirmed the range of IC50 values evaluated by DRAQ7, but not by the MTT assay. CONCLUSION: DRAQ7 is a better alternative than MTT for measuring viability of glioma cells treated with brightly coloured polyphenols. Copyright
Authors: Georges Da Violante; Naima Zerrouk; Isabelle Richard; Gérard Provot; Jean Claude Chaumeil; Philippe Arnaud Journal: Biol Pharm Bull Date: 2002-12 Impact factor: 2.233
Authors: Jin Akagi; Magdalena Kordon; Hong Zhao; Anna Matuszek; Jurek Dobrucki; Rachel Errington; Paul J Smith; Kazuo Takeda; Zbigniew Darzynkiewicz; Donald Wlodkowic Journal: Cytometry A Date: 2012-11-16 Impact factor: 4.355
Authors: David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison Journal: Acta Neuropathol Date: 2016-05-09 Impact factor: 17.088
Authors: Hao Jiang; Lijie Zhang; Jarret Kuo; Kelly Kuo; Subhash C Gautam; Laurent Groc; Alba I Rodriguez; David Koubi; Tangella Jackson Hunter; George B Corcoran; Michael D Seidman; Robert A Levine Journal: Mol Cancer Ther Date: 2005-04 Impact factor: 6.261
Authors: Markus D Siegelin; David E Reuss; Antje Habel; Abdelhaq Rami; Andreas von Deimling Journal: Neuro Oncol Date: 2008-10-29 Impact factor: 12.300
Authors: Yindong Mu; Jianjiang Dong; Hong Cui; Jiangping Hu; Jun Liang; Lei Yan Journal: Evid Based Complement Alternat Med Date: 2022-04-22 Impact factor: 2.650